CANF

Can Fite BioPharma News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Can Fite BioPharma Ltd CANF AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
0.06 3.33% 1.86 19:01:26
Open Price Low Price High Price Close Price Prev Close
1.85 1.69 1.86 1.84 1.80
more quote information »

Recent News

Date Time Source Heading
3/05/202107:25SEEKEnrollment underway in Can-Fite Bio's mid-stage COVID-19..
3/05/202107:18EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/05/202107:00BWCan-Fite Enrolls First Patient in Phase II COVID-19 Study..
2/22/202110:56SEEKCelsion, Citius Pharmaceuticals leads healthcare gainers;..
2/22/202107:41SEEKCan-Fite soars 45% on positive namodenoson data in liver..
2/22/202107:10BWNew Positive Data from Can-Fite’s Liver Cancer Phase II..
2/16/202109:55EDGARAmended Statement of Ownership (sc 13g/a)
2/09/202106:01EDGARAmended Statement of Ownership (sc 13g/a)
2/01/202107:05EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/01/202107:00BWCan-Fite Announces Inhibition of Liver Fibrosis by Cannabis..
1/29/202106:52EDGARAmended Statement of Ownership (sc 13g/a)
1/28/202107:06EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
1/28/202107:00BWCan-Fite’s NASH Indication Highlighted in Webinar by KOL Dr...
1/08/202108:24EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
1/08/202107:00BWCan-Fite Announces Publication of Namodenoson Liver Cancer..
12/15/202007:12EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
12/15/202007:00BWCan-Fite Receives Israel Ministry of Health Approval to..
12/14/202007:07EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
12/14/202007:00BWCan-Fite Reports on Progress With Its Namodenoson NASH..
12/09/202016:32EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
12/03/202007:00BWCan-Fite to Present at Benzinga Global Small Cap Conference..
11/30/202007:13EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/30/202007:00BWCan-Fite Reports Third Quarter 2020 Financial Results &..
11/24/202007:08EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/24/202007:00BWCan-Fite’s Namodenoson Abstract Selected as ‘Best of The..
11/23/202007:00BWCan-Fite to Conduct Investor Call to Review Q3 Results and..
11/16/202007:10EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/16/202007:00BWCan-Fite Presented NASH Phase II Namodenoson Data at a Late..
11/09/202007:00BWCan-Fite to Present its NASH Program in Fireside Chat at the..
11/06/202016:33EDGARSecurities Registration (ads, Immediate) (f-6ef)
10/28/202016:32EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
10/13/202007:00BWCan-Fite to Host Conference Call to Update Shareholders on..
10/06/202007:42EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
10/06/202007:30BWCan-Fite Announces Positive Phase III Psoriasis Interim Data..
9/30/202007:00BWCan-Fite Selected to Deliver Late-Breaking Oral Presentation..
9/25/202016:38EDGARSecurities Registration (foreign Private Issuer) (f-3)
9/22/202007:00BWCan-Fite to Participate in Two BioPharma Partnering..
9/08/202007:00BWCan-Fite to Present at H.C. Wainwright 22nd Annual Global..
9/08/202006:02EDGARNotice of Effectiveness (effect)
8/31/202007:11EDGARReport of Foreign Issuer (6-k)
8/31/202007:00BWFDA Clears Can-Fite to Commence Phase II COVID-19 Study
8/28/202016:34EDGARPost-effective Amendment to Registration Statement (pos Am)
8/27/202007:11EDGARReport of Foreign Issuer (6-k)
8/27/202007:00BWCan-Fite Reports Second Quarter 2020 Financial Results &..
8/25/202008:23EDGARReport of Foreign Issuer (6-k)
8/25/202008:09BWCan-Fite Receives Notification of Patent Grant from European..
8/20/202007:00BWCan-Fite to Conduct Investor Call to Review Q2 Results and..
8/12/202016:30EDGARReport of Foreign Issuer (6-k)
8/05/202016:28EDGARReport of Foreign Issuer (6-k)
7/27/202007:10EDGARReport of Foreign Issuer (6-k)
See more news about this stock »


Your Recent History
AMEX
CANF
Can Fite B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.